NCT01037036 - A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

July 31, 2010

Conditions

Ocular HypertensionOpen-Angle Glaucoma

Interventions

DRUG

Latanoprost Punctal Plug Delivery System

To evaluate the control of IOP compared to baseline, for an experimental dose of Latanoprost Punctal Plug Delivery System for 4 week or until loss of efficacy. This is a single arm study.

DRUG

Xalatan

Subjects will administer adjunctive Xalatan eye drops once daily for 2 weeks. This is a single arm study.

Trial Locations (1)

94025

Menlo Park, Menlo Park